Locations:
SearchAdvertisement
… however, scans to evaluate patients’ therapy response should be conducted to avoid continuing ineffective treatments.Dealing with COVID-infected cancer patients and cancer survivorsThe treatment approach for cancer patients diagnosed with COVID-19 will depend …
… Finally, Dr. Cheng highlights that big data sharing and research collaboration are essential to fight the rapid COVID-19 outbreak.Image note: The rendering of COVID-19 is courtesy of the Centers for Disease Control …
… were fully vaccinated at the time of transplantation.Following transplantation, none of the recipients tested positive for COVID-19. All of the kidneys were functioning, although delayed graft function was found in 19.6% of …
Many hospitals were unprepared to accommodate the surge in patients associated with the COVID-19 pandemic. A recently published study in the American Journal of Disaster Medicine describes how Cleveland Clinic, a large academic medical …
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers at Cleveland Clinic are in search of the biological reason behind why men are more likely than women to develop COVID-19 and typically have more severe disease.According to new study results published …
By Lauren M. Granat, DO, MS; Achintya D. Singh, MBBS, MD; Matthew Cortese, MD, MPH; Vicente Velez, MD, FACP, FHM; and Alan Lichtin, MDA 35-year-old woman with a medical history significant only for …
On the morning of Tuesday, March 10, 2020, executives from Nursing, Continuous Improvement, and Operations stood in the emergency command center on the Cleveland Clinic main campus to prepare and assimilate the impact of the …
With two vaccines for the novel coronavirus nearing emergency approval, federal and state governments assisted by healthcare organizations are preparing a massive national inoculation program that rivals the scope and urgency of polio vaccination in …
Moderna and Pfizer/BioNTech SE last week announced positive results from the interim analyses of phase-3 trial data of their respective vaccine candidates against COVID-19, mRNA-1273 and BNT162b2. Moderna’s mRNA-1273 …
Knowledge about the pathobiology of SARS-CoV-2 as it interacts with immune defenses is limited. SARS-CoV-2 is spread by droplets that come into contact with mucous membranes. COVID-19 is characterized by …
Advertisement
Advertisement